The impact of p53 and p73 on aneuploidy and cancer.

Trends in Cell Biology
Richard TomasiniGerry Melino

Abstract

Initiation, progression and evasion are sequential steps in cancer formation, with autonomous cell proliferation as a final outcome. Genetic or epigenetic alterations of key regulatory genes of the cell cycle are frequently associated with these phenomena. Recently, chromosomal instability, a long-supposed driving force of tumorigenesis, was associated with dysregulation of mitotic genes, providing advantages to tumor cells. Numerous molecules thus provide a key link in the chain of relationships between chromosomal instability and cancer. Here, we discuss emerging evidence revealing that two p53 family members, p53 and p73, might be key regulatory genes at the heart of the relationship between chromosomal instability and cancer. We argue that the role of members of the p53 family as tumor suppressor proteins, their impact on the control of cellular ploidy, and their newly emerging connection with mitotic checkpoint regulatory genes support the suggestion that p73 and p53 could be two of the missing links among chromosomal instability, the mitotic checkpoint and cancer.

References

Mar 15, 1979·Nature·D P Lane, L V Crawford
Mar 22, 1996·Science·K FukasawaG F Vande Woude
Jan 25, 2002·Journal of Cellular Physiology·Katya RavidMatthew R Jones
Jan 31, 2002·Trends in Genetics : TIG·Annie YangFrank McKeon
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Aug 3, 2002·Nature Reviews. Cancer·Gerry MelinoKaren H Vousden
Feb 11, 2003·Journal of Cellular Biochemistry·Robert L MargolisPaul R Andreassen
Aug 16, 2003·The Journal of Biological Chemistry·Marcella FulcoMassimo Levrero
Nov 18, 2003·Annual Review of Genetics·Daniel J Lew, Daniel J Burke
Jan 20, 2004·Genes & Development·Maranke I KosterDennis R Roop
Feb 6, 2004·The Journal of Experimental Medicine·Hitoshi OkadaTak W Mak
Jun 23, 2004·Nature Genetics·Darren J BakerJan M van Deursen
Aug 3, 2004·Nature Reviews. Cancer·Hitoshi Okada, Tak W Mak
Sep 18, 2004·Cancer Research·Katarina TomkovaAlexander I Zaika
Nov 3, 2004·Genes & Development·Uta KossatzNisar P Malek
Mar 2, 2005·Biochemical and Biophysical Research Communications·Steven A Innocente, Jonathan M Lee
May 4, 2005·Biochemical and Biophysical Research Communications·Anette Duensing, Stefan Duensing
May 5, 2005·Molecular and Cellular Biology·Tatsuo OikawaKenji Fukasawa
May 18, 2005·Genes, Chromosomes & Cancer·Paul KalitsisK H Andy Choo
Jun 30, 2005·The Journal of Biological Chemistry·Paola MerloMassimo Levrero
Aug 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aurora A BurdsPeter K Sorger
Sep 1, 2005·Genes & Development·Jean-Christophe BourdonDavid P Lane
Oct 1, 2005·Nature Reviews. Cancer·Geert J P L KopsDon W Cleveland
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicole ConcinRobert Zeillinger
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bibo YuanEdward Gabrielson
Mar 31, 2006·International Journal of Cancer. Journal International Du Cancer·Véronique OuelletAnne-Marie Mes-Masson
May 6, 2006·Journal of Cellular Biochemistry·Anette DuensingStefan Duensing
Oct 19, 2006·Current Opinion in Cell Biology·Beth A A Weaver, Don W Cleveland
Dec 27, 2006·Cancer Cell·Beth A A WeaverDon W Cleveland
Feb 1, 2007·Cell Cycle·Daniel AberdamMatthieu Rouleau
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Maranke I KosterDennis R Roop

❮ Previous
Next ❯

Citations

Nov 5, 2013·Oncogene·I AmelioG Melino
Jul 19, 2012·Annual Review of Cell and Developmental Biology·Jake J Siegel, Angelika Amon
Sep 23, 2008·Genes & Development·Richard TomasiniTak W Mak
Jan 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Richard TomasiniTak W Mak
Apr 25, 2009·PLoS Genetics·John S Mattick
Jan 9, 2010·Cell Death and Differentiation·Y NiikuraK Kitagawa
May 28, 2011·BMC Bioinformatics·Insuk SohnSin-Ho Jung
Jul 15, 2011·Clinical and Experimental Gastroenterology·Claire M PayneHarris Bernstein
Sep 2, 2011·Cell Death & Disease·R A Knight, G Melino
Jan 13, 2012·Cell Death & Disease·P SalomoniD Michod
Nov 26, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K Terada
May 27, 2009·Carcinogenesis·Francesco ColottaAlberto Mantovani
Nov 21, 2012·Briefings in Functional Genomics·A Kristine Jolliffe, W Brent Derry
Sep 11, 2012·Cell and Tissue Research·Adrian C MonkGary R Hime
Aug 2, 2012·Biochemistry Research International·Geun-Hyoung Ha, Eun-Kyoung Yim Breuer
Jan 23, 2016·Cellular and Molecular Life Sciences : CMLS·Sonja Matt, Thomas G Hofmann
Sep 13, 2015·The FEBS Journal·Alessandro Giamboi-MiragliaEleonora Candi
Jun 22, 2010·Journal of Cellular Biochemistry·Andrew H FischerPeter Kulesza
Aug 14, 2009·Molecular Carcinogenesis·Jessica DelBoveBernard E Weissman
May 8, 2015·Cell Cycle·Varvara PetrovaIvano Amelio
Apr 18, 2015·Cell Death and Differentiation·B ZhangB R Calvi
Jun 20, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hua LiuHongyun Wang
Jul 11, 2013·Cell Cycle·Paola TucciAnne E Willis
Aug 27, 2013·Cell Cycle·Giovanni ChillemiGerry Melino
Feb 15, 2011·Cell·Yun-Chi TangAngelika Amon
Oct 4, 2011·Biochemical and Biophysical Research Communications·Ivano AmelioRichard A Knight
Oct 6, 2011·Biochemical and Biophysical Research Communications·Alessandro Rufini, Gerry Melino
Feb 14, 2012·Experimental Cell Research·N AllocatiV De Laurenzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis